GGrantIndex
← Search

SAFETY OF ESTROGENS IN SLE NATIONAL ASSESSMENT (SELENA)

$0M01FY2002RRNIH

University Of Alabama At Birmingham, Birmingham AL

Investigators

Linked publications, trials & patents

Abstract

This study tries to address the effect of exogenous female hormones on disease activity and severity in postmenopausal patients with SLE. Patients will be enrolled and randomized to receive continuous conjugated estrogens pulus 5 mg. medroxiprogesterone for 10 days per month, or placebo for a follow-up of 12 months.

View original record on NIH RePORTER →